In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
The in vitro potency and in vivo efficacy of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae were investigated by pharmacokinetic studies with M. pneumoniae-infected hamsters. By using fluoroquinolones, macrolides, and tetracyclines as references, Q-35 was found to possess the greatest my...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1993
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188076/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8239590/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.9.1826 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
